These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 36564328)

  • 1. Exploring the Membership Pharmacy Model: Initial impact and feasibility.
    Hohmeier KC; Baker P; Storey C; Martin N; Gatwood JD
    J Am Pharm Assoc (2003); 2023; 63(2):672-680.e1. PubMed ID: 36564328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of community pharmacy tech-check-tech as a strategy for practice advancement.
    Fleagle Miller R; Cesarz J; Rough S
    J Am Pharm Assoc (2003); 2018; 58(6):652-658. PubMed ID: 30170967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
    Clark BE; Siracuse MV; Garis RI
    Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance-based pharmacy payment models: key components and critical implementation considerations for successful uptake and integration.
    Richard C; Urick BY; Pathak S; Jackson J; Livet M
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1568-1578. PubMed ID: 34714107
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of SyncPlus on workflow in an independent pharmacy.
    Cain M; Bormann T; Brosnahan K; Kryc C; Rodis J
    J Am Pharm Assoc (2003); 2024; 64(2):564-568. PubMed ID: 37995813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Optimizing Care Model: Final findings of a novel community pharmacy practice model to enhance patient care delivery using technician product verification.
    Hohmeier KC; Sain A; Garst A; Shell L; Desselle S; Gatwood J; Cost M
    J Am Pharm Assoc (2003); 2022; 62(1):112-119. PubMed ID: 34711522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
    Raisch DW
    Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist home visits: A 1-year experience from a community pharmacy.
    Monte SV; Passafiume SN; Kufel WD; Comerford P; Trzewieczynski DP; Andrus K; Brody PM
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):67-72. PubMed ID: 26802924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and effect of performance-based pharmacy payment models.
    Urick BY; Pathak S; Hughes TD; Ferreri SP
    J Manag Care Spec Pharm; 2021 Mar; 27(3):306-315. PubMed ID: 33645246
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting.
    Kirby J; Mousa N
    J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of medication synchronization on quality care criteria in an independent community pharmacy.
    Hinson JL; Garofoli GK; Elswick BM
    J Am Pharm Assoc (2003); 2017; 57(2):236-240. PubMed ID: 28089522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of technician-driven medication therapy management program in community pharmacies.
    Burnside TPT; Scott NJ; Smith MG
    J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a coordination of care program in an independent community pharmacy.
    Korn AS; Michaels NM; Phillips D; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S141-S145. PubMed ID: 31255520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.